Catamaran Corporation (Catamaran) is a provider of pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefit management industry. The Company operates in two segments: PBM and HCIT. The Company offers PBM services, which are marketed under the Catamaran PBM brand, and is engaged in owning and operating a network of mail and specialty pharmacies. In addition, the Company is a national provider of drug benefits to its customers under the federal government's Medicare Part D program. The Company's HCIT product offerings include a range of software products for managing prescription drug programs and for drug prescribing and dispensing. The Company's customers include organizations in the pharmaceutical supply chain, such as pharmacy benefit managers, managed care organizations, self-insured employer groups, unions, third-party healthcare plan administrators, and state and federal government entities.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Health Care Providers & Services
- Sub-Industry: Health Care Services
- Symbol: NASDAQ:CTRX
- CUSIP: 14888710
- Web: N/A
- 50 Day Moving Avg: $60.99
- 200 Day Moving Avg: $56.20
- 52 Week Range: $39.40 - $61.50
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 21.05
- P/E Growth: 0.00
- Average Volume: 2.80 million shs.
Frequently Asked Questions for Catamaran Corp (NASDAQ:CTRX)
What is Catamaran Corp's stock symbol?
Catamaran Corp trades on the NASDAQ under the ticker symbol "CTRX."
How were Catamaran Corp's earnings last quarter?
Catamaran Corp (NASDAQ:CTRX) released its earnings results on Thursday, February, 26th. The company reported $0.67 earnings per share for the quarter, beating the consensus estimate of $0.61 by $0.06. The business had revenue of $5.74 billion for the quarter, compared to the consensus estimate of $5.57 billion. The firm's revenue for the quarter was up 26.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.56 EPS. View Catamaran Corp's Earnings History.
Who are some of Catamaran Corp's key competitors?
Some companies that are related to Catamaran Corp include Merck KGaA (MKGAY), Hospira (HSP), Omnicare (OCR), Health Net (HNT), WuXi PharmaTech (Cayman) (WX), Hanger (HGR), SIGA Technologies (SIGA), Nobilis Health Corp (HLTH), Verastem (VSTM), Palatin Technologies (PTN), KaloBios Pharmaceuticals (KBIO), AdCare Health Systems (ADK), Capricor Therapeutics (CAPR), 3SBio (SSRX), Alexza Pharmaceuticals (ALXA), Allergan plc (WPI), Allergan plc (ACT) and Allos Therapeutics (ALTH).
How do I buy Catamaran Corp stock?
Shares of Catamaran Corp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Catamaran Corp's stock price today?
MarketBeat Community Rating for Catamaran Corp (NASDAQ CTRX)MarketBeat's community ratings are surveys of what our community members think about Catamaran Corp and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Catamaran Corp stock can currently be purchased for approximately $61.47.
Consensus Ratings for Catamaran Corp (NASDAQ:CTRX) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Catamaran Corp (NASDAQ:CTRX)
(Data available from 5/29/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|1/28/2016||JMP Securities||Upgrade||Underperform -> Market Perform||N/A|
Earnings History for Catamaran Corp (NASDAQ:CTRX)Earnings History by Quarter for Catamaran Corp (NASDAQ:CTRX)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|4/30/2015||Q1||$0.57||$0.59||$5.73 billion||$5.98 billion||View||N/A|
|2/26/2015||Q414||$0.61||$0.67||$5.57 billion||$5.74 billion||View||N/A|
|10/30/2014||Q314||$0.56||$0.58||$5.36 billion||$5.50 billion||View||N/A|
|8/1/2014||Q214||$0.51||$0.54||$5.01 billion||$5.40 billion||View||N/A|
|5/1/2014||Q114||$0.44||$0.50||$4.68 billion||$4.90 billion||View||N/A|
|2/27/2014||Q413||$0.54||$0.56||$4.04 billion||$4.53 billion||View||N/A|
|8/1/2013||Q2 2013||$0.44||$0.49||$3.47 billion||$3.38 billion||View||N/A|
|5/2/2013||Q1 2013||$0.41||$0.42||$3.53 billion||$3.18 billion||View||N/A|
|2/28/2013||Q4 2012||$0.35||$0.39||$3.33 billion||$3.33 billion||View||N/A|
|11/1/2012||Q312||$0.24||$0.25||$3.25 billion||$3.15 billion||View||N/A|
Earnings Estimates for Catamaran Corp (NASDAQ:CTRX)
Current Year EPS Consensus Estimate: $2.60 EPS
Next Year EPS Consensus Estimate: $2.92 EPS
Dividend History for Catamaran Corp (NASDAQ:CTRX)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Catamaran Corp (NASDAQ:CTRX)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Catamaran Corp (NASDAQ:CTRX)
Latest Headlines for Catamaran Corp (NASDAQ:CTRX)
|UnitedHealth Group boosts quarterly dividend, again|
finance.yahoo.com - June 8 at 8:50 AM
|How Aetna and Humana Benefited from UnitedHealth's Decisions (UNH, AET)|
www.investopedia.com - April 25 at 12:39 AM
|Walgreens Partners With UnitedHealth's OptumRx To Manage Prescriptions|
www.forbes.com - March 17 at 8:00 AM
|A.M. Best Assigns Ratings to UnitedHealth Group Incorporated's New Senior Unsecured Notes - Business Wire (press release)|
www.businesswire.com - February 24 at 5:42 PM
|Fitch Rates UnitedHealth Group's Planned Issuance 'A-(EXP)' - Business Wire (press release)|
www.businesswire.com - February 22 at 5:23 PM
|Analysts' Actions -- Cirrus Logic, Ford, Kinder Morgan, PayPal and More|
finance.yahoo.com - January 28 at 8:16 AM
|UnitedHealth loses $720M on Obamacare plans, but it’s got Optum|
www.bizjournals.com - January 19 at 3:55 PM
|Paul Tudor Jones Exits Positions in Motorola, Pall Corp.|
finance.yahoo.com - December 8 at 6:46 PM
|UnitedHealth's Impressive Growth Leaves Investors Wanting More|
www.fool.com - October 15 at 10:45 AM
|UnitedHealth Stock Might Deserve A Premium After Current M&A Cycle|
finance.yahoo.com - September 9 at 10:56 AM
|UNITEDHEALTH GROUP INCORPORATED Financials|
finance.yahoo.com - July 28 at 1:04 PM
|UnitedHealth Still Undervalued Despite Big Runup|
www.forbes.com - July 26 at 11:10 AM
|CATAMARAN CORP Files SEC form 8-K, Termination of a Material Definitive Agreement, Completion of Acquisition or Dispo|
biz.yahoo.com - July 23 at 5:04 PM
|Optumrx, Catamaran Complete Combination|
finance.yahoo.com - July 23 at 4:50 PM
|UnitedHealth Raises Over $10 Billion to Fund Catamaran Buyout|
finance.yahoo.com - July 21 at 5:45 PM
|UnitedHealth Group Incorporated -- Moody's rates UnitedHealth Group's senior notes A3; negative outlook|
www.moodys.com - July 20 at 9:35 AM
|UnitedHealth Group (UNH) Earnings Report: Q2 2015 Conference Call Transcript|
www.thestreet.com - July 16 at 12:04 PM
Catamaran Corp (CTRX) Chart for Monday, May, 29, 2017